Difference between revisions of "Cisplatin (Platinol)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m
Line 4: Line 4:
 
==General information==
 
==General information==
 
Class: Platinum analog, alkylating-like<ref name="insert">[http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/018057s080lbl.pdf Cisplatin package insert (8/2011)]</ref>
 
Class: Platinum analog, alkylating-like<ref name="insert">[http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/018057s080lbl.pdf Cisplatin package insert (8/2011)]</ref>
Extravasation: [[vesicant]]
+
<br>Extravasation: [[vesicant]]
  
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list additional information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer.  Instead, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the package insert<ref name="insert"></ref>.  
+
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer.  Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the package insert<ref name="insert"></ref>.  
  
 
==Consent==
 
==Consent==
*Side effects discussed for informed consent*
+
*Side effects discussed for informed consent
 
*Patient information for informed consent (patient drug information sheet)
 
*Patient information for informed consent (patient drug information sheet)
  
 
==Regimens==
 
==Regimens==
 
Standard format will be:
 
Standard format will be:
<nowiki><acronym (if any)> (generic drug1, generic drug2, generic drug3, etc.) (disease)</nowiki>
+
<br><nowiki><acronym (if any)> (generic drug1, generic drug2, generic drug3, etc.) (disease)</nowiki>
[http://hemonc.org/index.php?title=Special:WhatLinksHere/Cisplatin_(Platinol) List of regimens containing cisplatin]
+
<br>[http://hemonc.org/index.php?title=Special:WhatLinksHere/Cisplatin_(Platinol) List of regimens containing cisplatin]
  
 
==References==
 
==References==
 
<references/>
 
<references/>

Revision as of 07:27, 13 November 2011

Template to be used for chemotherapies: (strive for minimalism, focus on regimens)

General information

Class: Platinum analog, alkylating-like[1]
Extravasation: vesicant

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the package insert[1].

Consent

  • Side effects discussed for informed consent
  • Patient information for informed consent (patient drug information sheet)

Regimens

Standard format will be:
<acronym (if any)> (generic drug1, generic drug2, generic drug3, etc.) (disease)
List of regimens containing cisplatin

References